The harm reduction approach and risk factors for human immunodeficiency virus (hiv) seroconversion in injecting drug users, amsterdam

American Journal of Epidemiology

Volumn 136, Issue 2, 1992, Pages 236-243

  Van Ameijden, E J C ^a   Van Den Hoek, J A R ^a   Van Haastrecht, H J A ^a   Coutinho, R A ^a  

^a MUNICIPAL HEALTH SERVICE   (Netherlands)

Author keywords

Follow up studies; HIV infections; Incidence; Needles; Preventive health services; Risk factors; Substance abuse, intravenous

Indexed keywords

METHADONE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CONTROLLED STUDY; DISEASE CONTROL; DRUG ABUSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INJECTION; MAJOR CLINICAL STUDY; MALE; NEEDLE; NETHERLANDS; PREVENTIVE MEDICINE; PRIORITY JOURNAL; RISK FACTOR; SEROCONVERSION; SUBSTANCE ABUSE;

ADULT; FEMALE; HEALTH BEHAVIOR; HIV SEROPOSITIVITY; HIV-1; HUMAN; INCIDENCE; LIFE STYLE; LOGISTIC MODELS; MALE; NEEDLE SHARING; NETHERLANDS; PROSPECTIVE STUDIES; RESIDENCE CHARACTERISTICS; RISK FACTORS; SEX BEHAVIOR; SUBSTANCE ABUSE, INTRAVENOUS; SUPPORT, NON-U.S. GOV'T; TIME FACTORS;

EID: 0026669194     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a116489     Document Type: Article

References (23)

1. Marmor M, Des Jariais DC, Cohen H, et al. Risk factors for infection with HIV among intravenous drug users in New York City. AIDS 1987,1: 39-44.
2. Chaisson RE, Moss AR, Onishi R, et al. Human immunodeficiency virus infection in heterosexual intravenous drug users in San Francisco. Am J Public Health 1987;77:169-72.
3. van den Hoek JAR, Coutinho RA, van Haastrecht HJA, et al. Prevalence and risk factors of HIV infections among drug users and drug-using prostitutes in Amsterdam. AIDS 1988^:55-60.
4. Schoenbaum EE, Hartel D, Selwyn PA, et al. Risk factors for human immunodeficiency virus infection in intravenous drug users. N Engl J Med 1989; 321:874-9.
5. Schoenbaum EE, Hartel D, Friedland GH. Crack use predicts incident HIV seroconversion. Presented at the 6th International Conference on AIDS, San Francisco, 1990.
6. Moss A, Vranizan K, Bachetti P, et al. Seroconversion for HIV in intravenous drug users in treatment, San Francisco, 1985-1990. Presented at the 6th International Conference on AIDS, San Francisco, 1990.
7. Wiebel W, Lampinen T, Chene D, et al. HIV-1 seroconversion in a cohort of street intravenous drug users in Chicago. Presented at the 6th International Conference on AIDS, San Francisco, 1990.
8. Nicolosi A, Musicco M, Saracco A, et al. Incidence and risk factors of HIV infection: a prospective study of seronegative drug users from Milan and northern Italy, 1987-1989. Epidemiology 1990;1: 453-9.
9. Buning EC, Coutinho RA, van Brussel GHA, et al. Preventing AIDS in drug addicts in Amsterdam. (Utter). Lancet 1986;1:1435.
10. van den Hoek JAR, van Haastrecht HJA, Scheeringa- Troost B, et al. HIV infection and STD in drug-addicted prostitutes in Amsterdam: potential for heterosexual transmission. Genitourin Med 1989;65:146-50.
11. van den Hoek JAR, van Haastrecht HJA, Coutinho RA. Risk reduction among intravenous drug users in Amsterdam under the influence of AIDS. Am J Public Health 1989;79:1355-7.
12. van Haastrecht HJA, van den Hoek JAR, Bardoux C, et al. The course of the HIV epidemic among intravenous drug users in Amsterdam, the Netherlands. Am J Public Health 1991;81:59-62.
13. Drion J. Jaarverslag spuitomruilprogramma 1988. (In Dutch). Amsterdam: GG&GD, 1989.
14. Hartgers C, Buning EC, van Santen GW, et al. The impact of the needle and syringe exchange programme in Amsterdam on injecting risk behaviour. AIDS 1989;3:571-6.
15. Buning EC, van Brussel GHA, van Santen GW. The "methadone by bus" project in Amsterdam. Br J Addict 1990,85:1247-50.
16. Horsburgh CR, Jason J, Longini IM, et al. Duration of human immunodeficiency virus infection before detection of antibody. Lancet 1989;2:637-40.
17. Simmonds P, Lainson FAL, Cuthbert R, et al. HIV infection and antibody detection: variable response to infection in the Edinburgh haemophilic cohort. BMJ 1987;296:593-8.
18. Hosmer DW, Lemeshow S. Applied logistic regression. New York: John Wiley & Sons, Inc, 1989.
19. Klee H, Faugier J, Hayes C, etal. Factors associated with risk behavior among injecting drug users. AIDS Care 1990;2:133-45.
20. Hangers C, van Ameijden EJC, van den Hoek JAR, et al. Determinants of borrowing used needles and of not participating in the needle exchange programme among HIV-negative drug users. Public Health Rep (in press).
21. Vlahov D, Mufloz A, Anthony JC, et al. Association of drug injection patterns with antibody to human immunodeficiency virus type I among intravenous drug users in Baltimore, Maryland. Am J Epidemiol 1990; 132:847-56.
22. Donoghoe MC, Dolan KA, Stimson GV. Changes in injectors' HIV risk behaviour and syringe supply in UK, 1987-90. Presented at the 7th International Conference on AIDS, Florence, Italy, 1991.
23. Hartgers C, van den Hoek A (JAR), Krijnen P, et al. HIV prevalence and risk behavior among injecting drug users who participate in "lowthreshold" methadone programs in Amsterdam. Am J Public Health 1992,82:547-51.